Author Identifier (ORCID)
Abstract
Chronic kidney disease (CKD) affects approximately 674 million people worldwide and accounted for 35.6 million years of life lost in 2021.1 Premature mortality in CKD is driven largely by cardiovascular disease (CVD),2 and management of modifiable cardiometabolic risk factors remains essential alongside pharmacological renoprotection. Life's Essential 8 (LE8),3 a validated composite measure of cardiovascular health (CVH), has been associated with lower mortality in CKD,4 yet prior studies have relied on relative risk estimates, leaving the absolute survival benefit and the extent to which high CVH can close the life-expectancy gap between patients with and without CKD unclear. We therefore examined the association between CVH and remaining life expectancy in adults with CKD, and whether high CVH attenuates CKD-associated excess mortality relative to matched non-CKD individuals.
Keywords
cardiovascular health, chronic kidney disease, CVD mortality, life expectancy, Life's Essential 8
Document Type
Report
Date of Publication
8-1-2026
E-ISSN
27723747
Volume
6
Issue
8
Publication Title
JACC: Asia
Publisher
Elsevier
School
Nutrition and Health Innovation Research Institute / School of Medical and Health Sciences
Funding Information
This work was supported by the Yanzhao Gold Talent Project of Hebei Province (HJZD202506).
Creative Commons License
This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 4.0 License.
First Page
1891
Last Page
1893
Recommended Citation
Liu, P., Liu, D., Lan, Y., Zhang, Q., Lu, Q., An, K., Wang, J., Chen, S., Wu, S., & Wang, Y. (2026). Cardiovascular health and life expectancy in chronic kidney disease. JACC: Asia, 6(8), 1891–1893. https://doi.org/10.1016/j.jacasi.2026.05.032